1-1535436-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PS1_ModerateBS2
The NM_001114748.2(TMEM240):c.445G>A(p.Glu149Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000491 in 1,549,412 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in UniProt.
Frequency
Consequence
NM_001114748.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151974Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000203 AC: 3AN: 147648Hom.: 0 AF XY: 0.0000253 AC XY: 2AN XY: 78908
GnomAD4 exome AF: 0.0000515 AC: 72AN: 1397326Hom.: 1 Cov.: 33 AF XY: 0.0000450 AC XY: 31AN XY: 689212
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: TMEM240 c.445G>A (p.Glu149Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 147648 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.445G>A has been reported as a heterozygous genotype in the literature in at least one individual affected with Spinocerebellar Ataxia Type 21 (Delplanque_2014). This report does not provide unequivocal conclusions about association of the variant with the disorder. At least one publication reports experimental evidence evaluating the variant protein and found that it exhibits a similar pattern of cellular localization as wild-type TMEM240 (e.g. Seki_2018); however, this does not allow any strong conclusions to be made about its effect on protein function. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. -
not provided Uncertain:1
An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change does not substantially affect TMEM240 function (PMID: 30184469). ClinVar contains an entry for this variant (Variation ID: 1705200). This missense change has been observed in individual(s) with clinical features of TMEM240-related conditions (PMID: 25070513). This variant is present in population databases (rs546291208, gnomAD 0.01%). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 149 of the TMEM240 protein (p.Glu149Lys). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at